Advance ZincTek Past Earnings Performance
Past criteria checks 0/6
Advance ZincTek's earnings have been declining at an average annual rate of -55.5%, while the Chemicals industry saw earnings growing at 8.8% annually. Revenues have been declining at an average rate of 6.2% per year.
Key information
-55.5%
Earnings growth rate
-56.9%
EPS growth rate
Chemicals Industry Growth | 14.4% |
Revenue growth rate | -6.2% |
Return on equity | -2.6% |
Net Margin | -9.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Investors Could Be Concerned With Advance ZincTek's (ASX:ANO) Returns On Capital
Mar 14Here's What's Concerning About Advance ZincTek's (ASX:ANO) Returns On Capital
Oct 06Calculating The Fair Value Of Advance ZincTek Limited (ASX:ANO)
Aug 04Advance ZincTek (ASX:ANO) May Have Issues Allocating Its Capital
Jun 27The Returns On Capital At Advance ZincTek (ASX:ANO) Don't Inspire Confidence
Mar 10Be Wary Of Advance ZincTek (ASX:ANO) And Its Returns On Capital
Aug 12We Think The Compensation For Advance NanoTek Limited's (ASX:ANO) CEO Looks About Right
Oct 29Investors Will Want Advance NanoTek's (ASX:ANO) Growth In ROCE To Persist
Sep 30Advance NanoTek's (ASX:ANO) Returns On Capital Are Heading Higher
Jun 13Have Insiders Sold Advance NanoTek Limited (ASX:ANO) Shares Recently?
Mar 17Returns On Capital - An Important Metric For Advance NanoTek (ASX:ANO)
Mar 15Are Advance NanoTek's (ASX:ANO) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 17Read This Before Buying Advance NanoTek Limited (ASX:ANO) Shares
Jan 25Is Advance NanoTek Limited's (ASX:ANO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 07Do Institutions Own Advance NanoTek Limited (ASX:ANO) Shares?
Dec 21Why We Like The Returns At Advance NanoTek (ASX:ANO)
Dec 03We Wouldn't Rely On Advance NanoTek's (ASX:ANO) Statutory Earnings As A Guide
Jul 29Revenue & Expenses Breakdown
How Advance ZincTek makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 10 | -1 | 3 | 0 |
31 Mar 24 | 12 | 0 | 3 | 0 |
31 Dec 23 | 13 | 1 | 4 | 0 |
30 Sep 23 | 14 | 1 | 4 | 0 |
30 Jun 23 | 15 | 2 | 4 | 0 |
31 Mar 23 | 14 | 2 | 3 | 0 |
31 Dec 22 | 14 | 2 | 3 | 0 |
30 Sep 22 | 14 | 2 | 3 | 0 |
30 Jun 22 | 13 | 2 | 3 | 0 |
31 Mar 22 | 11 | 2 | 3 | 0 |
31 Dec 21 | 9 | 1 | 3 | 0 |
30 Sep 21 | 9 | 0 | 3 | 0 |
30 Jun 21 | 8 | 0 | 3 | 0 |
31 Mar 21 | 10 | 1 | 3 | 0 |
31 Dec 20 | 12 | 2 | 4 | 0 |
30 Sep 20 | 16 | 4 | 4 | 0 |
30 Jun 20 | 19 | 5 | 4 | 0 |
31 Mar 20 | 19 | 8 | 4 | 0 |
31 Dec 19 | 19 | 11 | 4 | 0 |
30 Sep 19 | 16 | 10 | 3 | 0 |
30 Jun 19 | 13 | 10 | 3 | 0 |
31 Mar 19 | 11 | 7 | 3 | 0 |
31 Dec 18 | 9 | 4 | 3 | 0 |
30 Sep 18 | 8 | 3 | 2 | 0 |
30 Jun 18 | 7 | 3 | 2 | 0 |
31 Mar 18 | 6 | 2 | 2 | 0 |
31 Dec 17 | 5 | 1 | 2 | 0 |
30 Sep 17 | 5 | 1 | 2 | 0 |
30 Jun 17 | 5 | 1 | 1 | 0 |
31 Mar 17 | 5 | 0 | 2 | 0 |
31 Dec 16 | 5 | 0 | 2 | 0 |
30 Sep 16 | 5 | 0 | 2 | 0 |
30 Jun 16 | 4 | 0 | 2 | 0 |
31 Mar 16 | 5 | 0 | 2 | 0 |
31 Dec 15 | 5 | 0 | 2 | 0 |
30 Sep 15 | 5 | 0 | 2 | 0 |
30 Jun 15 | 4 | 0 | 2 | 0 |
31 Mar 15 | 4 | 0 | 2 | 0 |
31 Dec 14 | 4 | 0 | 1 | 0 |
30 Sep 14 | 4 | 0 | 1 | 0 |
30 Jun 14 | 4 | 0 | 1 | 0 |
31 Mar 14 | 3 | 0 | 1 | 0 |
31 Dec 13 | 3 | -1 | 1 | 1 |
Quality Earnings: ANO is currently unprofitable.
Growing Profit Margin: ANO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ANO is unprofitable, and losses have increased over the past 5 years at a rate of 55.5% per year.
Accelerating Growth: Unable to compare ANO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ANO is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (3.9%).
Return on Equity
High ROE: ANO has a negative Return on Equity (-2.63%), as it is currently unprofitable.